pneumobacillus

(redirected from Klebsiella pneumoniae)
Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

pneu·mo·ba·cil·lus

 (no͞o′mō-bə-sĭl′əs, nyo͞o′-)
n. pl. pneu·mo·ba·cil·li (-sĭl′ī′)
A nonmotile, gram-negative bacterium (Klebsiella pneumoniae) that causes a severe form of pneumonia and is associated with other respiratory infections. Also called Friedländer's bacillus.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

pneumobacillus

(ˌnjuːməʊbəˈsɪləs)
n, pl -li (-laɪ)
(Pathology) a rod-shaped bacterium that occurs in the respiratory tract, esp the Gram-negative Klebsiella pneumoniae, which causes pneumonia
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

pneu•mo•ba•cil•lus

(ˌnu moʊ bəˈsɪl əs, ˌnyu-)

n., pl. -cil•li (-ˈsɪl aɪ)
an enterobacterium, Klebsiella pneumoniae, that is a cause of pneumonia and urinary tract infection.
[< New Latin; see pneumo-, bacillus]
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
Mentioned in ?
References in periodicals archive ?
Klebsiella pneumoniae are resistant to the carbapenem antibiotics - the last line of defence to treat infections - and are seen as extremely drug resistant.
The US FDA approved the product to treat patients 18 years of age and older who have limited or no alternative treatment options for cUTI, including pyelonephritis, caused by susceptible Gram-negative microorganisms such as Enterobacter cloacae, Escherichia coli, Klebsiella aerogenes, Klebsiella pneumoniae, and Pseudomonas aeruginosa.
Klebsiella is a species of bacteria that occurs naturally in the environment, but studies have shown that its subspecies, such as Klebsiella pneumoniae, are capable of causing a large number of infections, such as septicaemia (a form of blood poisoning), urinary tract infections and pneumonia.
Keywords: Plasmid-mediated AmpC beta-lactamases, PCR, Escherichia coli, Klebsiella pneumoniae.
In the US, the company's ZERBAXA 3g dose (ceftolozane 2g and tazobactam 1g) is indicated for treatment of patients 18 years and older with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) caused by the following susceptible Gram-negative microorganisms: Enterobacter cloacae, Escherichia coli, Haemophilus influenzae, Klebsiella oxytoca, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, and Serratia marcescens.
Food and Drug Administration has approved Merck's supplemental New Drug Application for the use of ZERBAXA for the treatment of patients 18 years and older with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by the following susceptible Gram-negative microorganisms: Enterobacter cloacae, Escherichia coli, Haemophilus influenzae, Klebsiella oxytoca, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, and Serratia marcescens.
Carbapenem-resistant Klebsiella pneumoniae has emerged as one of the major multidrug-resistant bacterial pathogens worldwide.
Ethanol and water fraction of the extract respectively have the highest activity against Staphylococcus aureus, while Escherichia coli, Klebsiella pneumoniae during the antibacterial screening.
Klebsiella pneumoniae is a Gram-negative bacterium, which is known as normal constituent of the human gastrointestinal tract.
Klebsiella pneumoniae is a Gram-negative facultative anaerobic bacterium and an important conditional pathogen in hospitals over the past years (1-3).
For quality control purpose Klebsiella pneumoniae ATCCA(r) BAA-1705 were used as positive control and Klebsiella pneumoniae ATCCA(r) BAA-1706 were used as negative control.